Plasma homocysteine, folate and B12 in chronic schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 6, 2007, Pages 1289-1296

  Haidemenos, Alexandros ^a   Kontis, Dimitrios ^a,b,c   Gazi, Anthia ^a   Kallai, Eleni ^a   Allin, Matthew ^c   Lucia, Boniatsi ^a  

^a Psychiatric Hospital of Attika Dafni   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

B12; Folate; Gender; Homocysteine; Schizophrenia

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLIC ACID BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SCHIZOPHRENIA; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; SEX FACTORS; VITAMIN B 12;

EID: 34447626495     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.05.011     Document Type: Article

References (35)

1. Adler-Nevo G.A., Meged S., Sela B.A., Hanoch-Levi A., Hershko R., and Weizman A. Homocysteine levels in adolescent schizophrenia patients. Eur Neuropsychopharmacol 16 8 (2006) 588-591
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Press, Washington DC
3. Applebaum J., Shimon H., Sela B.A., and Levine J. Plasma homocysteine levels in newly admitted schizophrenic patients. J Psychiatr Res 4 (2004) 413-416
4. Arinami T., Yamada N., Yamakawa-Kobayashi K., Hamaguchi H., and Toru M. Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am J Med Genet 74 (1997) 526-528
5. Brattstrom L., Wilcken D.E.L., Ohrvik J., and Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 98 (1998) 2520-2526
6. Brown A.S., Bottiglieri T., Schaefer C.A., Quesenberry Jr. C.P., Liu L., Bresnahan M., et al. Elevated prenatal homocysteine levels as a risk factor for schizophrenia. Arch Gen Psychiatry 64 1 (2007) 31-39
7. Chrysohoou C., Panagiotakos D.B., Pitsavos C., Zeimbekis A., Zampelas A., Papademetriou L., et al. The associations between smoking, physical activity, dietary habits and plasma homocysteine levels in cardiovascular disease-free people: the 'ATTICA' study. Vasc Med 9 2 (2004) 117-123
8. Golf D.C., and Coyle J.T. Thee of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 158 (2001) 1367-1377
9. Goff D.C., Bottiglieri T., Arning E., Shih V., Freudenreich O., Evins A.E., et al. Folate, homocysteine, and negative symptoms in schizophrenia. Am J Psychiatry 161 9 (2004) 1705-1708
10. Herran A., Garcýa-Unzueta M.T., Amado J.A., Lopez-Cordovilla J.J., Dýez-Manrique J.F., and Vazquez-Barquero J.L. Folate levels in psychiatric outpatients. Psychiatry Clin Neurosci 53 (1999) 531-533
11. Ho P.I., Ortiz D., Rogers E., and Shea T.B. Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res 1;70 5 (2002) 694-702
12. Jacques P.F., Bostom A.G., Wilson P.W., Rich S., Rosenberg I.H., and Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 73 (2001) 613-621
13. Joober R., Benkelfat C., Lal S., Bloom D., Labelle A., Lalonde P., et al. Association between the methylenetetrahydrofolate reductase 677CYT missense mutation and schizophrenia. Mol Psychiatry 5 (2000) 323-326
14. Kruman I.I., Culmsee C., Chan S.L., Kruman Y., Guo Z., Penix L., et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 15;20 18 (2000) 6920-6926
15. Kunugi H., Fukuda R., Hattori M., Kato T., Tatsumi M., Sakai T., et al. C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses. Mol Psychiatry 3 (1998) 435-437
16. Levine J., Stahl Z., Sela B.A., Gavendo S., Ruderman V., and Belmaker R.H. Elevated homocysteine levels in young male patients with schizophrenia. Am J Psychiatry 159 (2002) 1790-1792
17. Levine J., Sela B.A., Osher Y., and Belmaker R.H. High homocysteine serum levels in young male schizophrenia and bipolar patients and in an animal model. Prog Neuro-Psychopharmacol Biol Psychiatry 29 (2005) 1181-1191
18. Levine J., Stahl Z., Sela B.A., Ruderman V., Shumaico O., Babushkin I., et al. Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia. Biol Psychiatry 1;60 3 (2006) 265-269
19. Lipton S.A., Kim W., Choi Y., Kumar S., D'Emilia D.M., Rayadu P.V., et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor. Proc Natl Acad Sci U S A 94 (1997) 5923-5928
20. Mattson M.P., and Shea T.B. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26 3 (2003) 137-146
21. Miodownik C., Lerner V., Vishne T., Sela B.A., and Levine J. High-dose Vitamin B6 Decreases Homocysteine Serum Levels in Patients With Schizophrenia and Schizoaffective Disorders: A Preliminary Study. Clin Neuropharmacol 30 1 (2007) 13-17
22. Muntjewerff J.W., van der Put N., Eskes T., Ellenbroek B., Steegers E., Blom H., et al. Homocysteine metabolism and B-vitamins in schizophrenic patients: low plasma folate as a possible independent risk factor for schizophrenia. Psychiatry Res 121 1 (2003) 1-9
23. Muntjewerff J.W., Hoogendoorn M.L.C., Kahn R.S., Sinke R.J., Den Heijer M., Kluijtmans L.A.J., et al. Hyperhomocysteinemia, methylenetetrahydrofolate reductase 677TT genotype, and the risk for schizophrenia. A Dutch population based case-control study. Am J Med Genet B Neuropsychiatr Genet 135 (2005) 69-72
24. Muntjewerff J.W., Kahn R.S., Blom H.J., and den Heijer M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry 11 2 (2006) 143-149
25. Neeman G., Blanaru M., Bloch B., Kremer I., Ermilov M., Javitt D.C., et al. Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type. Am J Psychiatry 162 9 (2005) 1738-1740
26. Panagiotakos D.B., Pitsavos C., Zampelas A., Zeimbekis A., Chrysohoou C., Papademetriou L., et al. The association between coffee consumption and plasma total homocysteine levels: the "ATTICA" study. Heart Vessels 19 6 (2004) 280-286
27. Regland B., Johansson B.V., Grenfeldt B., Hjelmgren L.T., and Medhus M. Homocysteinemia is a common feature of schizophrenia. J Neural Transm 100 (1995) 165-169
28. Reif A., Schneider M.F., Kamolz S., and Pfuhlmann B. Homocysteinemia in psychiatric disorders: association with dementia and depression, but not schizophrenia in female patients. J Neural Transm 110 12 (2003) 1401-1411
29. Sakuta H., and Suzuki T. Alcohol consumption and plasma homocysteine. Alcohol 37 2 (2005) 73-77
30. Schneede J., Refsum H., and Ueland P.M. Biological and environmental determinants of plasma homocysteine. Semin Thromb Hemost 26 (2000) 263-279
31. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346 (2002) 476-483
32. Silver H. Vitamin B12 levels are low in hospitalized psychiatric patients. Isr J Psychiatry Relat Sci 37 1 (2000) 41-45
33. Stahl Z., Belmaker R.H., Friger M., and Levine J. Nutritional and life style determinants of plasma homocysteine in schizophrenia patients. Eur Neuropsychopharmacol 15 3 (2005) 291-295
34. Susser E., Brown A.S., Klonowski E., Allen R.H., and Lindenbaum J. Schizophrenia and impaired homocysteine metabolism: a possible association. Biol Psychiatry 44 (1998) 141-143
35. Virgos C., Martorell L., Simo J.M., Valero J., Figuera L., Joven J., et al. Plasma homocysteine and the methylenetetrahydrofolate reductase C677T gene variant: lack of association with schizophrenia. NeuroReport 10 10 (1999) 2035-2038